rs200735885

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001846.4(COL4A2):​c.1948C>T​(p.Pro650Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00174 in 1,613,708 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0017 ( 2 hom., cov: 34)
Exomes 𝑓: 0.0017 ( 7 hom. )

Consequence

COL4A2
NM_001846.4 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.433
Variant links:
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.021291971).
BP6
Variant 13-110465576-C-T is Benign according to our data. Variant chr13-110465576-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 311138.We mark this variant Likely_benign, oryginal submissions are: {Benign=4, Uncertain_significance=1}. Variant chr13-110465576-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00165 (252/152334) while in subpopulation AMR AF= 0.00203 (31/15308). AF 95% confidence interval is 0.00162. There are 2 homozygotes in gnomad4. There are 141 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High AC in GnomAd4 at 252 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL4A2NM_001846.4 linkuse as main transcriptc.1948C>T p.Pro650Ser missense_variant 25/48 ENST00000360467.7 NP_001837.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL4A2ENST00000360467.7 linkuse as main transcriptc.1948C>T p.Pro650Ser missense_variant 25/485 NM_001846.4 ENSP00000353654 P1

Frequencies

GnomAD3 genomes
AF:
0.00166
AC:
252
AN:
152216
Hom.:
2
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.00650
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00188
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00186
AC:
459
AN:
246218
Hom.:
3
AF XY:
0.00185
AC XY:
248
AN XY:
134004
show subpopulations
Gnomad AFR exome
AF:
0.0000652
Gnomad AMR exome
AF:
0.00183
Gnomad ASJ exome
AF:
0.000799
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000915
Gnomad FIN exome
AF:
0.00534
Gnomad NFE exome
AF:
0.00212
Gnomad OTH exome
AF:
0.00166
GnomAD4 exome
AF:
0.00174
AC:
2549
AN:
1461374
Hom.:
7
Cov.:
34
AF XY:
0.00178
AC XY:
1293
AN XY:
726998
show subpopulations
Gnomad4 AFR exome
AF:
0.000149
Gnomad4 AMR exome
AF:
0.00184
Gnomad4 ASJ exome
AF:
0.000460
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000928
Gnomad4 FIN exome
AF:
0.00573
Gnomad4 NFE exome
AF:
0.00177
Gnomad4 OTH exome
AF:
0.00147
GnomAD4 genome
AF:
0.00165
AC:
252
AN:
152334
Hom.:
2
Cov.:
34
AF XY:
0.00189
AC XY:
141
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.000241
Gnomad4 AMR
AF:
0.00203
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00186
Gnomad4 FIN
AF:
0.00650
Gnomad4 NFE
AF:
0.00188
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00171
Hom.:
2
Bravo
AF:
0.00121
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00183
AC:
15
ExAC
AF:
0.00172
AC:
208
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00142
EpiControl
AF:
0.00213

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxJan 13, 2020This variant is associated with the following publications: (PMID: 24036952) -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 23, 2024- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2022COL4A2: BS1, BS2 -
Optic nerve hypoplasia Uncertain:1
Uncertain significance, criteria provided, single submitterresearchRare Disease Group, Clinical Genetics, Karolinska InstitutetFeb 14, 2018COL4A2 mutations have been seen in optic nerve hypoplasia previously and the penetrance has been shown to be highly varying even within families. -
COL4A2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 23, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Porencephaly 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
11
DANN
Benign
0.97
DEOGEN2
Uncertain
0.53
D
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.78
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.67
T
M_CAP
Uncertain
0.091
D
MetaRNN
Benign
0.021
T
MetaSVM
Uncertain
0.042
D
MutationAssessor
Uncertain
2.1
M
MutationTaster
Benign
0.99
D
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-4.4
D
REVEL
Benign
0.21
Sift
Benign
0.11
T
Sift4G
Benign
0.088
T
Polyphen
0.011
B
Vest4
0.31
MVP
0.82
MPC
0.49
ClinPred
0.013
T
GERP RS
2.1
Varity_R
0.057
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200735885; hg19: chr13-111117923; COSMIC: COSV64628156; COSMIC: COSV64628156; API